According to filings with the U.S. Securities and Exchange Commission, Neuro42 is raising up to $7,350,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Amit Vohra played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Neuro42
neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions of neurological diseases and conditions. Named one of the Top 10 Great Companies to Work for in 2023. Stay tuned for more updates. Our product suite unifies an ecosystem of patented technologies to enable efficient diagnosis and targeted treatment of neurological conditions. Intraoperative robotic guidance under live imaging, powered by intelligent procedural planning and predictive analysis, is the future we envision.

To learn more about Neuro42, visit http://www.neuro42.ai/
Company Linkedin Page: https://www.linkedin.com/company/neuro42/

Contact:
Amit Vohra, Chief Executive Officer
480-241-3211
https://www.linkedin.com/in/amit-vohra/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.